01009nas a2200421   4500000000100000008004100001260001700042653001500059653001000074653000900084653001100093653001600104653001700120653002000137653003100157653001400188653002200202653001100224653002100235653001100256653001200267653000900279653001600288653002500304653001800329653001300347100001500360700001400375700001000389700001600399700001500415700001500430245007100445856004100516300000900557490000700566022001400573       1974                            d  c1974 Jan-Mar10aAdolescent10aAdult10aAged10aBiopsy10aClofazimine10aConstipation10aDrug Evaluation10aDrug Resistance, Microbial10aDyspepsia10aErythrocyte Count10aFemale10aHemoglobinometry10aHumans10aleprosy10aMale10aMiddle Aged10aMycobacterium leprae10aSkin Diseases10aSulfones1 aAzulay R D1 aSilva N C1 aZeo A1 aPortela A B1 aFranca J C1 aPeluso L L00aThe antileprotic action of clofazimine (B663, G30, 320, Lamprene).  uhttp://ila.ilsl.br/pdfs/v42n1a02.pdf  a13-80 v42  a0148-916X